-
Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027
Despite constraints due to the coronavirus pandemic, the Paris-based IRDiRC continues efforts for 1,000 new therapies and better rare disease care by 2027. Read more about it here.
What are your thoughts about this news?
Sorry, there were no replies found.
Log in to reply.